CareDx has agreed to acquire Naveris in a deal worth up to $260m, priming the company to inherit a blood‑based monitoring solution for viral‑mediated cancers.
CareDx’s deal for the precision oncology diagnostics company is structured...
CareDx has agreed to acquire Naveris in a deal worth up to $260m, priming the company to inherit a blood‑based monitoring solution for viral‑mediated...
US-based medical device company Nervonik has secured $52.5m in Series B financing aimed at advancing its peripheral nerve stimulation (PNS) system.
Amzak Health led the...
PlaqueTec, a MedTech company pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease (CVD), announced it has raised $5 million. The oversubscribed...
CorTec GmbH announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™ BCI system has successfully controlled...
LivaNova has published 12-month data supporting its proximal hypoglossal nerve stimulation (pHGNS) system for sleep apnea.
Findings come from the OSPREY study, which London-based LivaNova...
FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers.
Researchers at the University of Galway will...
Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...
CareDx has agreed to acquire Naveris in a deal worth up to $260m, priming the company to inherit a blood‑based monitoring solution for viral‑mediated...
US-based medical device company Nervonik has secured $52.5m in Series B financing aimed at advancing its peripheral nerve stimulation (PNS) system.
Amzak Health led the...
PlaqueTec, a MedTech company pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease (CVD), announced it has raised $5 million. The oversubscribed...